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Competition assayein p6⁎ known to modulate HIV-1 protease activation has been suggested to
interact with the viral pathogenicity factor Nef. However, a potential interaction site in p6⁎ has not been
mapped so far. To evaluate effects of p6⁎ modiﬁcation on viral replication in light of Nef function, clustered
substitutions were introduced into the central p6⁎ region of the infectious provirus NL4-3 and virus growth
and composition of the various mutants was analyzed in different cell cultures in the presence or absence of
Nef. Whereas clustered p6⁎ substitutions did neither affect particle incorporation of Nef, nor precursor
maturation or viral infectivity, a simultaneous substitution of 40 of the total 56 p6⁎ residues signiﬁcantly
diminished viral infectivity and replication in a Nef-independent manner. Furthermore, this extended
modiﬁcation was not capable of rescuing the negative effects of a transdominant Nef mutant on particle
production suggesting that the proposed target for Nef interaction in Gag-Pol is located outside the modiﬁed
p6⁎ region. In sum these data strongly argue against a functional connection of the central p6⁎ region and
Nef during viral life cycle.
© 2009 Elsevier Inc. All rights reserved.IntroductionThe human immunodeﬁciency virus type I (HIV-1) 9-kb genome is
organized in overlapping reading frames encoding all structural,
enzymatic and regulatory functions required to assemble infectious
virions.Whereas differential splicing of the pre-mRNA gives rise to the
viral envelope (Env) and several regulatory proteins (Tat, Rev, Nef, Vif,
Vpr and Vpu), the group speciﬁc Gag antigen and the Pol polyprotein
comprising the catalytic proteins protease (PR), reverse transcriptase
(RT) and integrase (IN) are produced from the unspliced 9-kb RNA
species. Conventional translation of this full-length mRNA results in
the production of a 55-kDa Gag polyprotein precursor (Pr55Gag) which
is cleaved by the viral PR during virus maturation into matrix protein
(MA), capsid protein (CA), nucleocapsid protein (NC), the late domain
protein p6 and the scarcely characterized spacer peptides p1 and p2
(summarized in Hill et al., 2005). In 5% of all translation events, a
heptanucleotide slippery site (UUUUUUA) together with an adjacent
RNA stem–loop structure promote a ribosomal frameshift in the NC-
p1 encoding region. This −1 frameshift results in the synthesis of a
160 kDa Gag-Pol polyprotein (Jacks et al., 1988; Wilson et al., 1988)
where the p1–p6Gag region is replaced by the transframe protein (TFP)
p6⁎ and the Pol domains PR-RT-IN.e (R. Wagner).
ll rights reserved.The relatively unstructured p6⁎ protein (Beissinger et al., 1996)
comprises 56–68 amino acids, depending on the respective HIV isolate
and is characterized by highly conserved amino- and carboxyl-
terminal regions and a less conserved central domain (Fig. 1). Within
Gag-Pol the TFP is located between the NC and PR domains and has
been shown to be subjected to sequential cleavage by the viral PR
during precursor maturation at two ﬂanking and one internal PR
cleavage sites (Almog et al., 1996; Chen et al., 2001; Louis et al., 1999;
Pettit et al., 2003; Zybarth et al., 1994). We and others have provided
evidence that p6⁎ plays an important role in the regulation of PR
activation (Paulus et al., 1999; Schramm et al., 1993; Zybarth et al.,
1994) and recombinant p6⁎ protein has been demonstrated to
speciﬁcally inhibit PR activity in vitro (Paulus et al., 1999). In this
context we have recently reported that mutations of the carboxyl-
terminal tetrapeptide of p6⁎ signiﬁcantly compromise viral replica-
tion in cell culture, depending on whether the p6⁎-PR cleavage site
was functionally affected (Paulus et al., 2004). Unlike the conserved
carboxyl-terminus, the central p6⁎ region appears to be highly
polymorphic and a preferred target of viral escape mutations evolving
under anti-retroviral therapy in HIV-1 infected individuals (Alexander
et al., 2000; Barrie et al., 1996; Cao et al., 2007; Ho et al., 2008; Ibe et
al., 2003; Peters et al., 2001). Apart from substitutions, extended
insertions in the p6⁎/p6gag region have been described in naïve and
anti-retroviral therapy-experienced patients (Ibe et al., 2003; Peters et
al., 2001) and deletions of up to 13 amino acids seem to be tolerated in
vivowithout a major impact on viral ﬁtness (Bleiber et al., 2004; Song
Fig. 1. Schematic representation of functional regions in p6⁎. The NL4-3 p6⁎ protein ﬂanked by the nucleocapsid (NC) and protease (PR) domains in the Gag-Pol precursor is
illustrated. The amino-terminal, central (grey) and carboxyl-terminal regions of p6⁎ are indicated with the highly conserved regions CR1 and CR2 (dotted lines), and the amino-
terminal (N), internal (I) and carboxyl-terminal (C) cleavage sites highlighted. The RNA region encoding the p6⁎ amino-terminus contains the frameshift signal for translation of the
pol gene. Some isolates carry a 12 amino acid insertion in the central p6⁎ region resulting in a 11 amino acid duplication. The entire p6⁎ encoding sequence and the 5′ part of the PR
are superimposed by the p1–p6gag sequence of the Gag open reading frame.
201A. Leiherer et al. / Virology 387 (2009) 200–210et al., 2007). While characterizing the genomes of early HIV-1 isolates,
Ratner et al. (1987) discovered a 36 bp insertion in the p6⁎/p6gag
region of isolate BH10 (provirus clone HX10) resulting in an 11 amino
acid duplication. This duplication which has also been found in virus
isolate BRU (provirus clone LAI) is absent in the common laboratory
strains HXB2 or NL4-3, although the gag-pol sequences of the
respective viruses are highly homologous. Interestingly, Ono et al.
(2000) have formerly demonstrated that deﬁciency of the viral
pathogenicity factor Nef has different effects on the replication of NL4-
3 and LAI virus clones in human leukemia cells. Mutational analysis
revealed that the determinants for this Nef-dependent effect were
located in the gag-pol region suggesting that Gag-Pol might be a
functional target of Nef and that this interaction might substantially
contribute to enhanced infectivity of Nef expressing HIV-I isolates.
This hypothesis was further substantiated in a study published by
Costa et al. (2004) which have proposed a direct interaction of p6⁎
and Nef. The authors have shown that Nef binds to Gag-Pol during
virus assembly via its ﬂexible carboxyl-terminal loop and could
further demonstrate that a Nef mutant comprising a deﬁcient
interaction site was no longer incorporated into virus particles.
As a distinct binding site within p6⁎ has not been determined so
far, we addressed in this study the proposed connection of Nef and p6⁎
via extended mutagenesis of the p6⁎ encoding sequence in the
provirus context in order to reveal phenotypic effects on viral
replication and infectivity. Whereas clustered mutations in p6⁎ had
no impact on the replicative capacity of Nef positive or Nef-deﬁcient
virus clones in different cell cultures, the substitution of the entire
central p6⁎ region revealed signiﬁcant effects on viral replication and
infectivity irrespective of Nef expression. Furthermore, none of the
examined mutations abrogated Nef packaging into virus particles
suggesting that the determinants for Nef interaction within Gag-Pol
were located outside the central p6⁎ region.
Results
The duplication of a central p6⁎ sequence inﬂuences the replication of
Nef-negative viruses in a cell type-dependent manner
In the context of elucidating the role of p6⁎ in viral replication, we
noticed a 36 bp, insertion (resulting in a 11 amino acid duplication of
the sequence SSEQTRANSPT) in the central part of p6⁎ naturally
occurring in a couple of virus isolates, such as BRU (Wain-Hobson et
al., 1985; GeneBank accession number: K02013) or BH10 (Ratner et al.,
1985). Earlier observations suggested that the infectivity of a NL4-3
provirus was more severely affected by a nef deletion than the BRU-
derived LAI provirus containing this 11 amino acid duplication in p6⁎
(Ono et al., 2000). These ﬁndings together with former reports by
Costa et al. (2004) proposing a functional connection of Nef and p6⁎
tempted us to speculate that the duplication might somehowcompensate for Nef deﬁciency. To investigate, whether there was a
functional link between the corresponding duplication in p6⁎ and the
absence of Nef, we compared the replicative capacity of two highly
homologous (96.8% identity) nef-deﬁcient proviruses of subtype B
origin: HX10 (99% identity to LAI), comprising the BH10-speciﬁc
duplication in p6⁎ (Ratner et al., 1987) and NL4-3Δnef lacking the
duplication. For this purpose, corresponding viruses were produced in
293T cells and were used to infect PBMCs from different donors and
permissive CEM lymphocytes (Fig. 2A). Interestingly, HX10 replicated
to higher virus titers in PBMCs, whereas NL4-3Δnef appeared to be
more successful in the CEM cell line. These data suggest that the
duplication in the central region of p6⁎ may have a cell type-speciﬁc
effect on viral replication in the absence of Nef.
Since the HX10 provirus comprising the p6⁎ duplication was
inherently lacking a functional nef open reading frame (ORF) we
further asked, whether HX10-derived virus particles were capable of
incorporating heterologous Nef. Thus, HX10 viruses were produced in
the presence of a NefNL4-3 expression construct. As illustrated in Fig.
2B, a speciﬁc product of 27-kDa was detected in HX10 particles
suggesting that Nef was successfully incorporated in the heterologous
virus.
Generation of virus mutants containing clustered substitutions in p6⁎
Costa et al. (2004) have formerly proposed that a direct interaction
of Nef with the p6⁎ domain of Gag-Pol might be responsible for
packaging of Nef into the virion. Whereas Nef has been shown to
interact with Gag-Pol via its carboxyl-terminal ﬂexible loop domain,
the target site within p6⁎ has not been mapped so far. In order to
further assess the proposed role of Nef and p6⁎ interaction in a virus
background, we introduced clusteredmutations into the p6⁎ region of
the Nef expressing provirus clone NL4-3. To generate signiﬁcant
modiﬁcations, all p6⁎ residues were substituted by unrelated amino
acids according to the Dayhoff matrix (Dayhoff et al., 1972) without
changing the amino acid sequence of the overlapping Gag ORF. In
order to (i) avoid modiﬁcations of the underlying frameshift signal
and (ii) to allow for efﬁcient release and activation of the viral PR,
mutations were limited to the central p6⁎ region leaving the very
amino- and carboxyl-terminal residues unaltered. In addition, the
HX10-derived fragment ISSEQTRANSPT was inserted into the other-
wise highly homologous p6⁎ protein of NL4-3 and a nef-deﬁcient
mutant thereof (Δnef) to reveal potential nef-speciﬁc effects of this
sequence on viral life cycle. A schematic presentation of the various
NL4-3-derived provirus mutants containing clustered p6⁎ mutations
(Ma-Mf) or the HX10-derived duplication (Mdup) is given in Fig. 3A.
Whereas mutations Mb-Mf and Mdup were restricted to the
central p6⁎ domain, Ma-speciﬁc substitutions E8, S12, K15 L16 and L17
were located in a region overlapped by the RNA stem–loop structure.
To exclude that these mutations, which slightly altered the calculated
Fig. 2. Replication kinetics of Nef-deﬁcient provirus clones HX10 and NL4-3Δnef. (A) 293T cells were transfected with the indicated provirus plasmids and particles released into cell
supernatants were quantiﬁed for p24CA content by ELISA. PBMCs of two different donors and CEM cells were infected in duplicate with normalized amounts of the virus-containing
supernatants, and spreading infections were monitored by quantiﬁcation of p24CA protein amounts at the indicated times. One representative experiment is shownwith error bars
indicating the SD of duplicate infections. (B) To analyze whether Nef was incorporated into Nef-deﬁcient HX10 particles, 293T cells were co-transfected with provirus HX10 and
either a NefNL4-3 expression plasmid or empty vector (mock). Virus containing supernatants were collected 72 h after transfection, ﬁltered (pore size 0.45 μm) and sedimented
through a 20% sucrose cushion. Particle-associated proteins were separated by SDS-PAGE and analyzed byWestern blot using a Nef-speciﬁc antiserum. Positions of molecular weight
markers are indicated at the left.
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frameshifting, frameshift reporter constructs were generated based on
a previously described reporter system (Paulus et al., 2004; Reil et al.,
1993). The frameshift sites of wt and mutant Ma were cloned 5′ of a
ﬁreﬂy luciferase gene allowing for the synthesis of luciferase
exclusively from the−1 frame, whereas translation is pre-terminated
at a stop codon in the 0 frame (Fig. 3C). As a positive control we used a
reporter harboring a modiﬁed slippery site resulting in constitutive
luciferase expression from the −1 frame (fs-luc). To compare
frameshift efﬁciency, 293Tcells were transfectedwith the correspond-
ing reporter plasmids fs-wt, fs-Ma, fs-luc or an empty vector (mock),
and cell-associated luciferase activity was quantiﬁed after 48 h. As
indicated in Fig. 3D, wt- and Ma-speciﬁc frameshift signals yielded
similar luminescence values corresponding to frameshift rates of 9.4%
and 9.7% respectively. This indicates that Ma-speciﬁc modiﬁcations
had no major impact on stem–loop stability and frameshift-mediated
Gag-Pol synthesis. These results are in accordancewith former reports
by Hill et al. (2002) describing a similar p6⁎ mutation introduced in
the context of p1gag analyses.
Inﬂuence of the p6⁎ substitutions on particle composition, infectivity and
cell-type speciﬁc replication
Since modiﬁcations in p6⁎would be expected to interfere with the
proposed Nef-p6⁎ interaction thereby potentially affecting Nef
incorporation into budding viruses, we analyzed the composition of
the various mutant particles released from transfected 293T cells by
Western blot. Equal amounts of Pr55Gag precursors and the mature
capsid protein p24CA were detected in wt and mutant viruses
suggesting that none of the p6⁎modiﬁcations affected particle release
or PR activation and subsequent processing of the viral Gag precursor
proteins (Fig. 4A). Further analysis of the particle preparations with a
Nef-speciﬁc antibody revealed a 27 kDa-Nef protein in all virus species
comprising a functional nef ORF and two smaller Nef-speciﬁc products
corresponding to a calculated molecular mass of 25 and 17 kDa as
previously described by Kotov et al., (1999). Whereas the latter
product indicates virus-associated cleavage of Nef by the viral PR
(Pandori et al., 1996; Welker et al., 1996), the weaker signal at 25 kDalikely represents an amino-terminally truncated Nef isoform trans-
lated from an internal ATG start codon (Greenway et al., 1994).
Although the various Nef forms appeared to be packaged at somewhat
different ratios, none of the central p6⁎ mutations Ma-Mf nor the
36 bp insertion in Mdup signiﬁcantly affected the overall incorpora-
tion of Nef into virions or Nef cleavage by the PR (Fig. 4A, left panel).
To exclude that Nef incorporation was solely guided by the
interactionwith the carboxyl-terminal residues of p6⁎, we transferred
the modiﬁed carboxyl-terminal p6⁎ residues PIDL of the previously
described HX10 provirus mutant csM5 (Ludwig et al., 2008) to the
NL4-3 p6⁎ sequence and analyzed the resulting virus particles for Nef
content (Fig. 4A, right panel). However, no inﬂuence of the modiﬁed
p6⁎ tetrapeptide on Nef incorporation could be observed suggesting
that neither the central nor the carboxyl-terminal residues of p6⁎
were responsible for packaging Nef into virions.
As Nef is a potent enhancer of viral infectivity in established cell
lines (Chowers et al., 1994), we further asked whether a functional
connection between Nef and p6⁎might become obviouswhen the p6⁎
mutants are analyzed in a single cycle replication assay. For this
purpose, all virus mutants excluding csM5 (which was formerly
demonstrated to exhibit a PR-speciﬁc loss in viral ﬁtness; Ludwig et
al., 2008) were produced in transfected 293T cells and used to infect
HeLa-CD4 indicator cells. As expected, infectivity of the Nef-depleted
Δnef virus was drastically reduced by 7-fold as compared to the Nef
expressing wt virus (Fig. 4B). While the Nef positive p6⁎mutants Ma-
Mf showed infection rates within a range of ±30% of wt infections,
Mdup viruses displayed a 60% increase in infectivity compared to wt
particles. Analogously, the duplication raised the infectivity of the
Δnef virus from 14% to 41% of wt level. However, MdupΔnef did not
reach infection levels of Nef positive viruses indicating that the 36-bp
insertion in the central p6⁎ region did not compensate for Nef
deﬁciency.
The various p6⁎ mutants were further compared for their
capability to grow on different cell lines. Conﬁrming the results of
the infectivity assay, growth rates of Nef-deﬁcient viruses (Δnef and
MdupΔnef) were signiﬁcantly reduced in PBMCs as indicated by
strongly delayed replication curves and low maximum virus titers
determined by p24CA ELISA (Fig. 4C). In contrast, all other virus
Fig. 3. Generation of proviral p6⁎mutants. (A) Clusteredmutations were introduced into the central p6⁎ region (highlighted in grey) of provirus NL4-3 (wt) resulting in mutants Ma-
Mf. Unaltered amino acids are represented by dashed lines and those amino acids overlapping the RNA region involved in frameshifting are marked by a shaded line. The carboxyl-
terminal tetrapeptide of p6⁎ forming a PR cleavage half-site is maintained in all mutants. A HX10-derived 12 amino acid insertionwithin p6⁎ (printed in bold) has been transferred to
NL4-3 yielding mutant Mdup. (B) Nucleic acid substitutions in the stem–loop region of Ma compared to wt stem–loop are indicated by black arrows. Stem–loop structures were
predicted according to (Zuker, 2003) and (Walter et al., 1994) with the calculated free energy values (ΔG) shown below. (C)Wt andMa-speciﬁc frameshift regionswere cloned 5′ of a
ﬁreﬂy luciferase reporter gene to allow for frameshift-dependent expression of luciferase from the −1 frame. The luciferase reading frame is depicted in grey and nucleotide
positions in Ma altered with respect to the wt frameshift site are underlined. A construct with a modiﬁed slippery sequence driving frameshift-independent reporter synthesis from
the−1 frame was used as positive control (fs-luc). (D) Fs reporter constructs or an empty vector (mock) were used to transfect 293T cells, and cell-associated luciferase activity was
quantiﬁed after 48 h. Luciferase activity (relative light units, RLU) determined for fs-luc was set to 100% and all other values were related, accordingly. One representative plot
comprising mean values and SD from three independent transfection experiments is shown.
203A. Leiherer et al. / Virology 387 (2009) 200–210mutants yielded wt-like replication kinetics (exemplarily shown for
mutant Mc), as illustrated for day ﬁve post transfectionwhenwt-peak
titers were determined (Fig. 4C, bar chart).
A comparable replication study using established CEM lympho-
cytes revealed a slower spread of viral infections than on PBMCs, with
higher maximum wt titers measured at day thirteen post infection.
Nevertheless, the effect of Nef on replication was still evident.
Reﬂecting the observations using PBMCs, we did not detect any effect
of p6⁎ mutants Ma-Mf (exemplarily shown for mutant Mc) on virus
growth rate on CEM cells. However, in this cell line, the corresponding
duplication in p6⁎ appeared to slightly delay replication of mutant
MdupΔnef which basically conﬁrms the data shown in Fig. 2A and
suggests a cell line-dependent effect of the p6⁎ insertion. The
relatively high p24CA titers measured in Δnef and MdupΔnef samples
at day 17 post infection are likely due to the fact, that the slower
replication of Nef-deﬁcient viruses allows for a strong growth of the
rapidly proliferating CEM cells resulting in a larger amount of cells
available for infection at a later time point.
Finally the variousmutantswere grown on highly permissiveMT-4
lymphocytes, which are known to promote viral growth independentof Nef (Day et al., 2004). Indeed, both Nef-deﬁcient viruses (Δnef and
MdupΔnef) showed wt-like replication curves and reached compar-
able p24CA titers. Furthermore, none of the p6⁎ mutations affected
viral replication conﬁrming the results obtained with PBMCs and CEM
cells. Together these data imply that the clusteredmutationsMa-Mf in
the p6⁎ region had no signiﬁcant inﬂuence on viral replication kinetics
in Nef sensitive cell cultures suggesting that either no relevant Nef
binding motif in p6⁎ was affected by the corresponding substitutions
or that abrogation of the proposed p6⁎–Nef interaction had only
minor effects on viral ﬁtness that do not become obvious in single
replication formats.
As we could not observe any severe effects of the central p6⁎
mutations on viral replication or infectivity in the various cell lines,
we employed a more sensitive dual competition assay that was
recently developed to directly compare the viral ﬁtness of wild-type
and mutant viruses replicating together in a single cell system
(Ludwig et al., 2008). Therefore, CEM cells were infected by wt
viruses mixed with mutants Ma-Mf or Mdup at a ratio of 1:1 and
the spread of infection in the cell cultures was monitored by analysis
of cell-derived genomic DNA for integrated virus genomes.
Fig. 4. Inﬂuence of clustered p6⁎mutations on particle composition, infectivity and replication. (A) 293T cells were transiently transfected with the indicated proviral plasmids and
particles released into cell supernatants were harvested 72 h post-transfection and sedimented through a 20% sucrose cushion. Particle-associated proteins were separated by SDS-
PAGE and analyzed by Western blot using p24CA- and Nef-speciﬁc antisera. Positions of molecular weight markers are shown at the left, and arrows at the right indicate speciﬁc
protein bands. (B) To evaluate viral infectivity, virus containing supernatants from 293T cells were harvested 72 h post transfection, normalized for p24CA content by ELISA and used
to infect CD4-positive HeLa indicator cells. Forty-eight hours post-infection, blue cells were counted and obtained values were related to wt-infections (=100%). Error bars indicate
the SD of triplicate infections. (C) To analyze viral replication kinetics, PBMCs, CEM and MT-4 cells were infected in duplicate with normalized amounts of virus-containing
supernatants and spreading infections were monitored by quantiﬁcation of p24CA amounts in culture supernatants by ELISA. Mutants displaying wt-like replication curves were
omitted for clarity. p24CA amounts measured in all samples at time points of wt peak titers are depicted in bar chart diagrams below. One representative experiment is shown with
error bars indicating the SD of duplicate infections.
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signal peaks from wt and mutated p6⁎ sequences (Fig. 5A). Ratios of
wt versus mutant peak heights were calculated for days 1, 12 and 21
to determine the time post infection at which wt is overgrown by a
mutant or vice versa (Fig. 5B). In accordance with the above results,
Ma-Mf replicated with roughly the same efﬁciency as the wt virus
suggesting that the corresponding mutations did not compromise
viral ﬁtness (Fig. 5C). In contrast, the Mdup mutant was less
successful and overgrown by wt virus by factor 2.3 at the end of the
observation period (Figs. 5B and C). Whereas a negative inﬂuence of
the p6⁎ duplication on the replication of Nef-deﬁcient viruses in
CEM cells was readily observed in single replication cultures (Fig. 2,
Fig. 4C), the loss of viral ﬁtness in the Nef-positive background only
became visible in direct competition with wt virus. In sum these
ﬁndings indicate that the insertion of the 11 amino acid duplication
in the central p6⁎ region negatively affects viral ﬁtness in CEM cells
irrespective of Nef.Substitution of the entire central p6⁎ region does not rescue the negative
effect of a transdominant Nef protein but severely affects viral infectivity
and replication
Apart from the HX10-derived duplication, none of themutations in
p6⁎ resulted in a distinct phenotype in the various cell cultures
analyzed. As a short mutated region might not be sufﬁcient to induce
signiﬁcant effects, we constructed an additional mutant including all
Ma-Mfmutations (Mtot), thus resulting in the substitution of 38 of the
total 56 p6⁎ amino acid residues (Fig. 6A). However, Western blot
analysis of the resulting virus particles with p24CA and Nef-speciﬁc
antibodies did not reveal any effect of the extended p6⁎ mutation on
particle release, Gag precursor processing or incorporation of Nef as
compared to wt particles (Fig. 6B).
To further clarify, whether the central p6⁎ region might be a target
for Nef binding, we co-transfected Δnef andMtotΔnef proviruses with
a defective NefF12 protein formerly shown to interfere with virus
Fig. 5. Dual competition of wild-type andmutant viruses in permissive T-lymphocytes. Wt andmutant viruses obtained from transient transfection of 293T cells were normalized for
p24CA amounts and mixed at a 1:1 ratio prior to infection of CEM cells. At day 1, 12 and 21 post infection, genomic DNA from infected cells was prepared, and the p6⁎ region of
integrated virus genomeswas sequenced. (A) Sections of the resulting chromatograms comprising themutated p6⁎ region are exemplarily shown for wt : Mc andwt : Mdup samples.
Infections of wt and mutant sequences are reﬂected by overlapping peak signals at the indicated nucleotide positions (asterisks). (B) Ratios of wt versus mutant peak heights were
determined for all indicated positions within a chromatogram, averaged to one mean ratio per analyzed time point and plotted in a binary logarithm chart. (C) The shift of the wt
versus mutant ratio at day 21 post dual infection has been summarized for all individual analyses. The previously described virus mutant csM5 harboring a modiﬁed p6⁎-PR cleavage
site displayed a severely reduced replication competence (Ludwig et al., 2008) and was therefore used as a control in this assay. All assays were performed in duplicate.
205A. Leiherer et al. / Virology 387 (2009) 200–210production and Gag processing. NefF12 displays an atypical sub-
cellular distribution and has been proposed to retain Gag-Pol
polyproteins in the perinuclear compartment thereby causing a
drastically reduced particle release (Costa et al., 2004; D'Aloja et al.,
1998; Fackler et al., 2001; Federico et al., 1995, 1996; Olivetta et al.,
2000). If this retention was indeed mediated by a speciﬁc interaction
of Nef and p6⁎, the extended p6⁎ mutation in Mtot might preventNefF12 from binding to Gag-Pol thereby overcoming the negative
effect of NefF12 on particle release. To prove this hypothesis, 293Tcells
were either transfectedwith Nef expressing wt andMtot proviruses or
were co-transfected with Δnef or MtotΔnef constructs and either a
NefF12 expression plasmid or an empty vector (mock). Culture
supernatants were quantiﬁed by p24CA ELISA 24 h and 48 h post
transfection to reveal differences in particle production (Fig. 6C). We
Fig. 6. Inﬂuence of central p6⁎ mutations on Nef incorporation and particle release. (A) The entire central p6⁎ region of NL4-3 (highlighted in grey) was substituted by non-
conservative amino acids yielding mutant Mtot. Residues involved in the carboxyl-terminal cleavage of p6⁎ remained unaltered. (B) 293T cells were transfected with indicated
proviral plasmids and virus containing supernatants were collected 72 h post-transfection and analyzed byWestern blot with p24CA- and Nef-speciﬁc antibodies. (C) 293T cells were
co-transfected with indicated proviral constructs and either a NefF12 expression plasmid or empty vector (mock), and virus containing supernatants were collected 24 or 48 h post-
transfection and analyzed for p24CA protein amounts by ELISA.
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in the absence of Nef expression (compare lanes 2 and 5 to lanes 1 and
4, respectively). In contrast, co-expression of the deﬁcient NefF12
resulted in a signiﬁcant reduction of both,Δnef andMtotΔnef particles
in culture supernatants which was particularly obvious 48 h post
transfection (Fig. 6C, lanes 3 and 6). As NefF12 protein reduced the
production of wild-type and mutant viruses to a similar extent, we
conclude that the Mtot-speciﬁc modiﬁcations in the central part of
p6⁎ did not disrupt the proposed interaction of Gag-Pol with Nef.
These ﬁndings suggest that the proposed Nef binding site is (i) either
located in the unmodiﬁed amino-terminus or (ii) outside of p6⁎.
Irrespective of the NefF12-speciﬁc effects we noticed that the Mtot
modiﬁcations resulted in a slight reduction of particle release, both in
the absence or presence of functional Nef (Fig. 6C, compare lanes 4
and 5 to 1 and 2, respectively). To further reveal potential effects of the
extended Mtot substitutions on viral infectivity, Mtot and MtotΔnef
containing supernatants were titrated on HeLa-CD4 indicator cells and
compared with wt and Δnef viruses expressing wild-type p6⁎. As
expected, both virus species lacking Nef were far less infectious than
the Nef expressing counterparts (Fig. 7A). However, the non-
conservative mutation of the entire central p6⁎ region resulted in a
50% (compare wt and Mtot) and 43% (compare Δnef and MtotΔnef)
reduction of viral infectivity.
Given that virus particles used for the above infectivity analysis
were normalized with a p24CA antibody detecting primarily the
processed p24CA species, we had to take into account possible effects
of the p6⁎ modiﬁcations on PR activation and subsequent precursor
processing which might have altered the ﬁnal ratio of precursor-
associated versus free p24CA proteins. To assure that the various p6⁎
mutations did not compromise PR activity, virus particle preparations
of all p6⁎ mutants were lysed and treated with an excess of
recombinant HIV-1 PR to cleave all residual unprocessed Gag and
Gag-Pol precursors. Resulting p24CA amounts were quantiﬁed by
ELISA and compared to the values obtained prior to PR treatment. Asillustrated in Fig. 7B, a control virus (csM7) harbouring a incompletely
activated PR (Ludwig et al., 2008) yielded a fourfold increase in
detectable p24CA protein amounts providing evidence that the
quantity of precursor-associated p24CA signiﬁcantly inﬂuences the
p24CA amounts determined by ELISA. In contrast, the p24CA content of
all virus preparations including Mtot was not signiﬁcantly altered
following PR treatment. In sum, these data suggest that none of the
mutations in p6⁎ affected PR activation and precursor processing.
Finally, we analyzed the replicative capacity of the Mtot and
MtotΔnef mutants compared to thewild-type counterparts on PBMCs,
CEM and MT-4 cells. Interestingly, the complete mutation of the
central p6⁎ region slightly delayed replication curves of both, Nef
expressing and Nef-deﬁcient viruses (Fig. 7C). This effect was even
more pronounced in CEM cells, where no productive replication of the
MtotΔnef mutant could be detected. As previously shown, viral
growth in MT-4 lymphocytes was completely independent of Nef.
However, in MT4-cells, the replication of the Mtot variants was very
similar to wt proﬁles, suggesting that this cell line was basically less
sensitive towards mutation-speciﬁc effects.
Although the sequential mutation of the p6⁎ central region had no
visible effect on viral ﬁtness, substitution of the entire center as well as
the insertion of a 11 amino acid duplication clearly diminished viral
infectivity and replication in a cell-type dependent manner. Since the
compromised phenotypes of the p6⁎ mutants were independent of
Nef expression, we conclude that the central region of p6⁎ has no
functional connection to Nef protein during viral life cycle.
Discussion
We have formerly reported that clustered mutations in the central
region of p6⁎ did not impact on particle release, viral replication or
infectivity as long as the amino-terminal frameshift signal and the
carboxyl-terminal PR cleavage site of p6⁎ remained intact (Paulus et
al., 2004). Hence, to guarantee correct frameshifting and providing a
Fig. 7. Inﬂuence of central p6⁎ mutations on viral infectivity, replication kinetics and PR activity. (A) To determine viral infectivity, 293T cells were transfected with indicated viral
plasmids and virus containing supernatants were harvested 72 h post-transfection and quantiﬁed for p24CA content. Equal amounts of p24CA were then used to infect HeLa-CD4
indicator cells. Forty-eight hours later, cells infected by the virus mutants were counted and obtained values were related towt-infections (=100%). (B) To determine the amounts of
incompletely processed particle-associated Gag proteins, virus containing supernatants were quantiﬁed for p24CA content before and after incubation with an excess of recombinant
HIV-1 PR. The corresponding changes in p24CA content after processing of wt particles in transwas set to 100% and all other values were related accordingly. As control, a virus mutant
containing an incompletely activated PR was used. Experiments were performed in quadruplicate and the SD is indicated. (C) To analyze viral replication kinetics, PBMCs, CEM and
MT-4 cells were infected in duplicate with normalized amounts of virus-containing supernatants and spreading infections were monitored by quantiﬁcation of p24CA amounts in
culture supernatants by ELISA. p24CA amounts measured in all samples at time points of wt peak titers are depicted in bar chart diagrams below. One representative experiment is
shown with error bars indicating the SD of duplicate infections.
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p6⁎ sequence in vivo (Ludwig et al., 2008), whereas the central p6⁎
residues largely deﬁned by the overlapping p6gag reading frame rather
seem to exert a spacer function.
Notably, these earlier mutational analyses were performed in a
Nef-deﬁcient virus background and did therefore not address
potential Nef-speciﬁc effects. In order to further elucidate p6⁎ function
in light of the formerly proposed interaction with Nef (Costa et al.,
2004) we used a Nef expressing virus clone for extended mutational
analysis of the p6⁎ region. By introducing clusteredmutations into the
central p6⁎ region we could show that neither particle assembly and
precursor maturation nor infectivity and viral growth or packaging of
Nef proteins was signiﬁcantly affected. Further to that also the
substitution of the highly conserved carboxyl-terminal tetrapeptide of
p6⁎ did not prevent Nef incorporation. Costa et al. (2004) have
demonstrated that the incorporation of Nef into virions correlatedwith the capability of Nef to interact with Gag-Pol and proposed that
p6⁎was the target for Nef bindingwithin the Gag-Pol precursor. Based
thereon, it has been suggested that Nef might improve the efﬁciency
of Gag-Pol trafﬁcking to the viral assembly sites via interaction with
p6⁎ thereby positively affecting subsequent particle release.
Although there are valid arguments supporting a functional
association of Nef and Gag-Pol, a speciﬁc mechanism has not been
unraveled to date. In the same year, Ciufﬁ et al. (2004) have published a
study where Nef has been shown to interact with other viral core
components including IN, PR and RT suggesting that Nef might
encounter different Pol binding partners during the viral life cycle.
Furthermore, former studies have provided evidence that particle-
associated Nef is speciﬁcally cleaved by the viral PR (Freund et al., 1994;
Gaedigk-Nitschko et al., 1995; Miller et al., 1997; Pandori et al., 1996;
Welker et al.,1996) and the interaction of processedNefwidth viral core
proteins implicates that Nef accompanies the RT and the preintegration
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infectivity have been shown to vary among isolates and cell lines
(D'Aloja et al., 2001; Giese et al., 2006; Luo and Garcia, 1996; Tokunaga
et al., 1998) and cell type-speciﬁc differences in replication point to a
potential role of cellular factors involved in Nef–Gag-Pol interaction. To
this end, it has been suggested that Nef and Gag-Pol, both co-localizing
at cytoplasmic assembly sites, might form complexes with cellular
kinases (Coates et al., 1997; Ono et al., 2000; Sawai et al., 1995).
Taking into account the complexity of the large Gag-Pol precursor,
single clustered mutations in the central p6⁎ region would probably
be insufﬁcient to disturb an interaction of Nef and Gag-Pol that might
be inherently conformation-dependent. To address this issue, we
designed an additional p6⁎ mutant where 40 of the entire 56 amino
acids were substituted simultaneously. Albeit still not abrogating the
incorporation of Nef, this extended p6⁎ mutation signiﬁcantly
decreased viral infectivity and retarded viral replication in a cell-
type dependent manner which, however, proved to be independent of
Nef expression. As a negative effect of the Mtot mutation on the
activity of the viral PR could be widely excluded, the reason for this
replication-impaired phenotype remains to be determined. We
suppose that the large modiﬁcation in p6⁎ might impose a steric or
conformational hindrance on the Gag-Pol precursor thereby interfer-
ing with optimal precursor dimerization and assembly of virions. This
hypothesis gets support from the slightly diminished particle release
observed after transfection of Mtot provirus. Nevertheless, the Mtot
mutation was not capable of rescuing particle release in the presence
of the transdominant NefF12mutant that had formerly been shown to
interfere with viral assembly by trapping Gag-Pol in an intracellular
compartment (Costa et al., 2004; D'Aloja et al., 1998; 2001; Fackler et
al., 2001; Federico et al., 1995, 1996; Olivetta et al., 2000). These data
support the assumption that the proposed target for Nef interaction is
located outside the central p6⁎ region.
Although we cannot exclude that Nef might speciﬁcally bind to the
amino-terminal octapeptide of p6⁎ that was not modiﬁed due to the
overlapping frameshift signal, a leading role of p6⁎ in packaging Nef
seems rather unlikely. In this respect, a previous study by Chiu et al.
(2006) has shown that the deletion of p6⁎ from aGag-Pol precursor had
no effect on Gag-Pol incorporation into budding particles and our recent
data indicate that the majority of p6⁎ is completely dispensable for
particle release and viral replication (Leiherer et al., unpublished data).
In view of the distinctive variability of the p6⁎ sequence, insertions
into the proximal p6gag/p6⁎ region often resulting in sequence
duplications have been observed in a broad panel of virus isolates
from naïve and HAART-treated individuals (Barrie et al., 1996; Bleiber
et al., 2004; Ibe et al., 2003; Marlowe et al., 2004; Peters et al., 2001;
Song et al., 2007; Whitehurst et al., 2003). Whereas most of these
polymorphisms contribute to anti-retroviral drug resistance or viral
immune evasion from CTL responses (Cao et al., 2007; Ibe et al., 2003,
2008) some of these modiﬁcations are associated with severe
deﬁciencies in particle release or precursor processing (Bleiber et al.,
2004; Whitehurst et al., 2003). Peters et al. (2001) have formerly
reported that plasma viruses with a duplication in the p6gag/p6⁎
region showed improved infectivity but at the same time displayed
delayed protein maturation. Similar effects might be responsible for
the ambiguous behavior of the Mdupmutant, comprising an 11 amino
acid duplication in the p6gag/p6⁎ region. As earlier reports demon-
strated that Nef deﬁciency had a more drastic impact on the
replication of virus clone NL4-3 than on LAI, the latter harboring the
corresponding p6gag/p6⁎ insertion (Ono et al., 2000), we were
tempted to speculate that this sequence might be involved in Nef-
mediated enhancement of viral infectivity. Indeed, signiﬁcant differ-
ences in the replication proﬁles of Nef-deﬁcient NL4-3 and HX10
viruses were observed, which were however, dependent on the cell
culture used. Although NL4-3 and HX10 display a 96.8% homology, it is
important to note that sequence variations outside the p6 region may
contribute to the observed phenotypes of these viruses, as recentlyreported by Hill et al. (2007). To exclude this possibility, the HX10-
derived duplication was transferred to NL4-3. Interestingly, this
insertion augmented viral infectivity in a monocyclic replication
assay in the presence and absence of Nef. Furthermore, the effect of
the inserted fragment on the replicative capacity of the viruses was
quite inconsistent in different cell cultures. Whereas the duplication
did not visibly affect viral growth on primary cells and MT-4
lymphocytes, the replication of Mdup viruses on CEM cells was
clearly delayed when grown together with wild-type in a dual
competition assay. Nevertheless, the observed Mdup-speciﬁc effects
were independent of Nef suggesting a potential role of cellular factors.
Insertional mutagenesis in the virus context becomes particularly
challenging in light of the overlapping gag and pol reading frames as
insertions into the p6⁎ sequence involve insertions into the p1-p6gag
ORF (Ludwig et al., 2008). Most of the reported insertions result in a
duplication of the PTAP motif in p6gag which has been shown to
signiﬁcantly alter binding to the cellular factor Tsg101 during the late
stage of virus assembly with possible impact on budding efﬁciency
(VerPlank et al., 2001). In contrast, the outcome of p6⁎ insertions is
rather elusive andmight be outcompeted by p6gag-speciﬁc effects. One
possibility to solve this problem has been previously described by Hill
et al. (2001) and Shehu-Xhilaga et al. (2001). By co-expressing
separate Gag and Gag-Pol encoding constructs, effects of individual
mutations on viral maturation, assembly and particle composition can
be analyzed without modifying the otherwise overlapping reading
frame. However, the co-expression of separate constructs does not
result in infectious replicating viruses and would therefore not allow
for evaluation of mutation-speciﬁc effects in the early phase of rep-
lication. To address this issue, an artiﬁcial replication-competent virus
platform has recently been designed exhibiting uncoupled gag and pol
reading frames (Leiherer et al., unpublished data) thereby providing
new options for in-depth analysis of p6⁎ function during virus life
cycle.
Materials and methods
Generation of provirus mutants
Fragments carrying clustered mutations in the central p6⁎ region
were introduced into provirus clone NL4-3 (Adachi et al., 1986) via type
II restriction sites resulting in mutants Ma-Mf and csM5, respectively.
Likewise, a fragment where the entire central p6⁎ region was
substituted, was cloned into NL4-3 and NL4-3Δnef to obtain mutants
Mtot andMtotΔnef. In addition, a NL4-3-derived p6⁎ fragment carrying
the central 11 amino acidduplication fromHIV-1 isolate BH10 (Ratner et
al., 1987) (the duplication covers amino acids 448–470 in p6⁎ with
respect to BH10 Gag ATG) was cloned into NL4-3 and NL4-3Δnef
yielding Mdup and MdupΔnef. All synthetic p6⁎ fragments were
purchased fromGeneart AG (Regensburg, Germany) and the p6⁎ region
of the modiﬁed provirus mutants was veriﬁed by sequencing. Plasmids
were propagated in E. coli SURE cells (Stratagene, Heidelberg, Germany)
to avoid deletions. To obtain the plasmid NefNL4-3, the nef region of NL4-
3was ampliﬁed by polymerase chain reaction andwas inserted into the
eukaryotic expression vector pcDNA3.1 (Invitrogen, Carlsbad, CA) via
ﬂanking BamHI and EcoRI restriction sites.
Generation of frameshift luciferase reporter constructs
To allow for frameshift-dependent expression of a ﬁreﬂy luciferase
reporter gene, synthetic fragments corresponding to the NL4-3-
derived frameshift region comprising the slippery sequence and a 3′
stem–loop structure as well as the corresponding region of mutantMa
were generated by Geneart AG (Regensburg, Germany) and intro-
duced into pGL2-Control vector (Promega, Mannheim, Germany) via
HindIII and XbaI restriction sites yielding constructs fs-wt and fs-Ma,
respectively. An additional reporter construct fs-luc with a modiﬁed
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frame was generated accordingly.
Cell culture
Adherent 293T human kidney epithelial cells were grown in
Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with
10% heat-inactivated fetal calf serum (FCS), 100 U/ml penicillin, and
100 μg/ml streptomycin. HeLa-CD4-LTR-β-gal indicator cells (Kimpton
and Emerman, 1992) were obtained from the NIH AIDS Research and
Reference Reagent Program and were maintained in DMEM plus FCS
and streptomycin/penicillin supplemented with 0.2 mg/ml G418 and
0.1mg/ml hygromycine B. Peripheral bloodmononuclear cells (PBMCs)
were isolated from healthy human donors by Pancoll (Pan Biotech
GmbH, Aidenbach, Germany) density gradient centrifugation of whole
blood (950 ×g, 30 min) andwere stimulated with phytohemagglutinin
(0.5 μl/ml) for 2 days. PBMCs and thepermissive humanTcell lines CEM
and MT-4 were maintained in RPMI 1640 medium supplemented with
10% FCS, 100 U/ml penicillin, and 100 μg/ml streptomycin.
Virus production and CA quantiﬁcation
Wild-type and mutant viruses were produced by transient
transfection of 2×106 293T cells with proviral plasmids using
FuGENE® 6 (Roche Diagnostics, IN, USA) according to the manufac-
turer's instructions. Alternatively, cells were transfected with calcium
phosphate using 50 μg of proviral plasmid. Virus containing super-
natants were collected 3 days post-transfection, ﬁltered (pore size,
0.45 μm) and quantiﬁed for total amounts of particle-associated p24CA
protein by enzyme-linked immunosorbent assay (ELISA) using CA-
speciﬁc antibodies from Polymun (Vienna, Austria) as recently
described (Ludwig et al., 2008).
Analysis of virus proteins by Western blot
Transfected 293T cells and extracellular particles in culture super-
natants were harvested 72 h post transfection and were prepared as
described previously (Paulus et al., 2004). The total amount of protein
within cell lysates and particle preparations was determined using the
Bio-Rad protein assay (Munich, Germany) according to the manufac-
turer's protocol, and equal amounts of total protein were separated by
SDS-polyacrylamide gel electrophoresis and transferred to nitrocellu-
lose. Viral proteinswere visualized using the p24CA-speciﬁcmonoclonal
antibody 13/5 (Wolf et al., 1990) or the Nef-speciﬁc sheep antiserum
ARP 444 (MRC AIDS Reagent Project) together with horseradish
peroxidase-conjugated antibodies followed by enhanced chemilumi-
nescence detection (SuperSignal, Pierce Chemical, Rockford, IL, USA).
Analysis of virus replication and infectivity
Virus-containing supernatants produced in 293T cells were
normalized for p24CA concentration by ELISA. For infection of CEM
and MT-4 cells, 1×106 cells were pelleted in duplicate and
resuspended in virus supernatants corresponding to 250 ng of
p24CA. Cell suspensions were adjusted to 1 ml with medium and
incubated for 6 h at 37 °C. Infected cells werewashed and resuspended
in 4ml of medium and further incubated at 37 °C. PBMCs were treated
accordingly using 50 ng p24CA for infection and the culture medium
was supplementedwith 20 U/ml interleukin-2 (IL-2). Culture samples
were taken every 2 days to quantify p24CA by ELISA and proliferating
cultures were diluted by 1:2 with fresh medium. To determine virus
infectivity, 1.3×104 HeLa-CD4-LTR-β-gal indicator cells were incu-
bated with equal amounts of virus containing supernatants quantiﬁed
for p24CA by ELISA. After 48 h, cells were washed, ﬁxed and stained as
described previously (Paulus et al., 2004), and blue cells were counted
in a light microscope.Growth competition assay
Competitive growth of wild-type andmutant viruses was analyzed
as recently described in (Ludwig et al., 2008). Brieﬂy, 2×106 CEM cells
were infected in duplicate with wild-type and mutant particles at a
ratio of 1:1. At given times, cell samples were collected and genomic
proviral DNA was extracted and sequenced. The resulting chromato-
gramswere analyzed using Vector NTI 10.3.0 software from Invitrogen
(Karlsruhe, Germany).
Frameshift luciferase reporter assay
3×105 293T cells were transiently transfected with 12 μg of the
luciferase reporter constructs via calcium phosphate precipitation.
Forty-eight hours post transfection cells were harvested and analyzed
for luciferase activity using the Luciferase assay from Promega as
described previously (Paulus et al., 2004) after adequate dilution of
the samples.
PR activity assay
To determine the amount of precursor-associated CA proteins,
pelleted particles from culture supernatants of transfected 293T cells
were resuspended in PBS and quantiﬁed for p24CA protein amounts by
ELISA. Particles were then diluted 1:50 in PR assay buffer (100 mM
NaOAc [pH5.0], 0.5MNaCl, 4mMEDTA, 5mMdithiothreitol, 0.1%Triton
X-100 (w/v)), solubilized by vortexing, and subsequently incubated
with 250 nM of recombinant HIV-1 protease dimer (Bachem) for 2 h at
37 °C. P24CA protein amounts of PR-treated samples were quantiﬁed by
ELISA and compared to the values obtained prior to PR treatment.
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